C117H137F8N31O7 — CID 157269264
[(4-ethylpiperazin-1-yl)-[6-[[5-fluoro-4-(7-fluoro-2-methyl-3-propan-2-ylbenzimidazol-5-yl)pyrimidin-2-yl]amino]-3-pyridinyl]methyl] acetate;[(S)-(4-ethylpiperazin-1-yl)-[6-[[5-fluoro-4-(7-fluoro-2-methyl-3-propan-2-ylbenzimidazol-5-yl)pyrimidin-2-yl]amino]-3-pyridinyl]methyl] acetate;[(R)-(4-ethylpiperazin-1-yl)-[6-[[5-fluoro-4-(7-fluoro-2-methyl-3-propan-2-ylbenzimidazol-5-yl)pyrimidin-2-yl]amino]-3-pyridinyl]methyl] acetate;5-fluoro-4-(7-fluoro-2-methyl-3-propan-2-ylbenzimidazol-5-yl)-N-[5-[[1-(3-methoxypropyl)piperidin-4-ylidene]methyl]-2-pyridinyl]pyrimidin-2-amine (PubChem CID 157269264) has the molecular formula C117H137F8N31O7 and a molecular weight of 2241.58 g/mol. Its IUPAC name is [(4-ethylpiperazin-1-yl)-[6-[[5-fluoro-4-(7-fluoro-2-methyl-3-propan-2-ylbenzimidazol-5-yl)pyrimidin-2-yl]amino]-3-pyridinyl]methyl] acetate;[(S)-(4-ethylpiperazin-1-yl)-[6-[[5-fluoro-4-(7-fluoro-2-methyl-3-propan-2-ylbenzimidazol-5-yl)pyrimidin-2-yl]amino]-3-pyridinyl]methyl] acetate;[(R)-(4-ethylpiperazin-1-yl)-[6-[[5-fluoro-4-(7-fluoro-2-methyl-3-propan-2-ylbenzimidazol-5-yl)pyrimidin-2-yl]amino]-3-pyridinyl]methyl] acetate;5-fluoro-4-(7-fluoro-2-methyl-3-propan-2-ylbenzimidazol-5-yl)-N-[5-[[1-(3-methoxypropyl)piperidin-4-ylidene]methyl]-2-pyridinyl]pyrimidin-2-amine.
| Compound Name | [(4-ethylpiperazin-1-yl)-[6-[[5-fluoro-4-(7-fluoro-2-methyl-3-propan-2-ylbenzimidazol-5-yl)pyrimidin-2-yl]amino]-3-pyridinyl]methyl] acetate;[(S)-(4-ethylpiperazin-1-yl)-[6-[[5-fluoro-4-(7-fluoro-2-methyl-3-propan-2-ylbenzimidazol-5-yl)pyrimidin-2-yl]amino]-3-pyridinyl]methyl] acetate;[(R)-(4-ethylpiperazin-1-yl)-[6-[[5-fluoro-4-(7-fluoro-2-methyl-3-propan-2-ylbenzimidazol-5-yl)pyrimidin-2-yl]amino]-3-pyridinyl]methyl] acetate;5-fluoro-4-(7-fluoro-2-methyl-3-propan-2-ylbenzimidazol-5-yl)-N-[5-[[1-(3-methoxypropyl)piperidin-4-ylidene]methyl]-2-pyridinyl]pyrimidin-2-amine |
|---|---|
| PubChem CID | 157269264 |
| Molecular Formula | C117H137F8N31O7 |
| Molecular Weight | 2241.58 g/mol |
| Exact Mass | 2240.12 |
| IUPAC Name | [(4-ethylpiperazin-1-yl)-[6-[[5-fluoro-4-(7-fluoro-2-methyl-3-propan-2-ylbenzimidazol-5-yl)pyrimidin-2-yl]amino]-3-pyridinyl]methyl] acetate;[(S)-(4-ethylpiperazin-1-yl)-[6-[[5-fluoro-4-(7-fluoro-2-methyl-3-propan-2-ylbenzimidazol-5-yl)pyrimidin-2-yl]amino]-3-pyridinyl]methyl] acetate;[(R)-(4-ethylpiperazin-1-yl)-[6-[[5-fluoro-4-(7-fluoro-2-methyl-3-propan-2-ylbenzimidazol-5-yl)pyrimidin-2-yl]amino]-3-pyridinyl]methyl] acetate;5-fluoro-4-(7-fluoro-2-methyl-3-propan-2-ylbenzimidazol-5-yl)-N-[5-[[1-(3-methoxypropyl)piperidin-4-ylidene]methyl]-2-pyridinyl]pyrimidin-2-amine |
| SMILES | CCN1CCN(C(OC(C)=O)c2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1.CCN1CCN([C@@H](OC(C)=O)c2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1.CCN1CCN([C@H](OC(C)=O)c2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1.COCCCN1CCC(=Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1 |
| InChI | InChI=1S/C30H35F2N7O.3C29H34F2N8O2/c1-19(2)39-20(3)35-29-24(31)15-23(16-26(29)39)28-25(32)18-34-30(37-28)36-27-7-6-22(17-33-27)14-21-8-11-38(12-9-21)10-5-13-40-4;3*1-6-37-9-11-38(12-10-37)28(41-19(5)40)20-7-8-25(32-15-20)35-29-33-16-23(31)26(36-29)21-13-22(30)27-24(14-21)39(17(2)3)18(4)34-27/h6-7,14-19H,5,8-13H2,1-4H3,(H,33,34,36,37);3*7-8,13-17,28H,6,9-12H2,1-5H3,(H,32,33,35,36)/t;2*28-;/m.10./s1 |
| InChIKey | AYIRMZAUYCCVKM-QFABDJRXSA-N |
| XLogP | 21.31 |
| TPSA | 384.89 Ų |
| H-Bond Donors | 4 |
| H-Bond Acceptors | 38 |
| Rotatable Bonds | 33 |
| Heavy Atoms | 163 |
| Complexity | — |
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2241.58 |
| LogP ≤ 5 | 21.31 |
| H-Bond Donors ≤ 5 | 4 |
| H-Bond Acceptors ≤ 10 | 38 |
| Structural Alerts | {'alert_name': '>_2_ester_groups', 'substructure': 'N/A'}, {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'} |
|---|